272 related articles for article (PubMed ID: 30395903)
1. Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy.
Pearlstein KA; Wang K; Amdur RJ; Shen CJ; Dagan R; Weiss J; Grilley-Olson JE; Zanation A; Hackman TG; Thorp BD; Blumberg JM; Patel S; Sheets N; Weissler MC; Mendenhall WM; Chera BS
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):646-653. PubMed ID: 30395903
[TBL] [Abstract][Full Text] [Related]
2. Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Chera BS; Amdur RJ; Tepper JE; Tan X; Weiss J; Grilley-Olson JE; Hayes DN; Zanation A; Hackman TG; Patel S; Sheets N; Weissler MC; Mendenhall WM
Cancer; 2018 Jun; 124(11):2347-2354. PubMed ID: 29579339
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.
Hegde JV; Shaverdian N; Daly ME; Felix C; Wong DL; Rosove MH; Garst JH; Wang PC; Veruttipong D; Rao S; Fragoso RC; Riess JW; Steinberg ML; Chen AM
Cancer; 2018 Feb; 124(3):521-529. PubMed ID: 29044458
[TBL] [Abstract][Full Text] [Related]
4. Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Chera BS; Amdur RJ; Green R; Shen C; Gupta G; Tan X; Knowles M; Fried D; Hayes N; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Zevallos J; Blumberg J; Patel S; Kasibhatla M; Sheets N; Weissler M; Yarbrough W; Mendenhall W
J Clin Oncol; 2019 Oct; 37(29):2661-2669. PubMed ID: 31411949
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients.
Høxbroe Michaelsen S; Grønhøj C; Høxbroe Michaelsen J; Friborg J; von Buchwald C
Eur J Cancer; 2017 Jun; 78():91-102. PubMed ID: 28431302
[TBL] [Abstract][Full Text] [Related]
6. A prospective evaluation of patient-reported quality-of-life after (chemo)radiation for oropharyngeal cancer: which patients are at risk of significant quality-of-life deterioration?
Al-Mamgani A; van Rooij P; Tans L; Verduijn GM; Sewnaik A; Baatenburg de Jong RJ
Radiother Oncol; 2013 Mar; 106(3):359-63. PubMed ID: 23395066
[TBL] [Abstract][Full Text] [Related]
7. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer.
Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N
JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238
[TBL] [Abstract][Full Text] [Related]
8. Quality of Life and Depression Symptoms After Therapy De-Escalation in HPV+ Oropharyngeal Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
Panwar A; Shah S; Reid AE; Lydiatt W; Holcomb AJ; Osmolak A; Coughlin A; Militsakh O; Su YB; Mirmiran A; Huang TS; Nolan N; Duckert R; Barney C; Chiu M; Nguyen C; Sayles H; Ganti AK; Lindau R
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):429-435. PubMed ID: 38573597
[TBL] [Abstract][Full Text] [Related]
9. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.
Xu MJ; Plonowska KA; Gurman ZR; Humphrey AK; Ha PK; Wang SJ; El-Sayed IH; Heaton CM; George JR; Yom SS; Algazi AP; Ryan WR
Laryngoscope; 2020 Feb; 130(2):E48-E56. PubMed ID: 30919470
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in head and neck cancer patients: impact of HPV and primary treatment modality.
Maxwell JH; Mehta V; Wang H; Cunningham D; Duvvuri U; Kim S; Johnson JT; Ferris RL
Laryngoscope; 2014 Jul; 124(7):1592-7. PubMed ID: 24353066
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy.
Tsai CJ; McBride SM; Riaz N; Kang JJ; Spielsinger DJ; Waldenberg T; Gelblum D; Yu Y; Chen LC; Zakeri K; Wong RJ; Dunn L; Pfister DG; Sherman EJ; Lee NY
JAMA Oncol; 2022 Mar; 8(3):364-372. PubMed ID: 35050342
[TBL] [Abstract][Full Text] [Related]
12. Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of life.
Wang K; Amdur RJ; Mendenhall WM; Green R; Aumer S; Hackman TG; Zanation AM; Zevallos JP; Patel SN; Weissler MC; Chera BS
Oral Oncol; 2016 Jul; 58():21-6. PubMed ID: 27311398
[TBL] [Abstract][Full Text] [Related]
13. Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer.
Mavroidis P; Price A; Fried D; Kostich M; Amdur R; Mendenhall W; Liu C; Das S; Marks LB; Chera B
Radiother Oncol; 2017 Aug; 124(2):240-247. PubMed ID: 28712533
[TBL] [Abstract][Full Text] [Related]
14. Prospective quality of life outcomes for human papillomavirus associated oropharynx cancer patients after surgery alone.
Stephens EM; Plonowska-Hirschfeld K; Gulati A; Kansara S; Qualliotine J; Zelbolsky AL; van Zante A; Ha PK; Heaton CM; Ryan WR
Am J Otolaryngol; 2023; 44(4):103915. PubMed ID: 37210888
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
[TBL] [Abstract][Full Text] [Related]
16. Gastrostomy tube dependence and patient-reported quality of life outcomes based on type of treatment for human papillomavirus-associated oropharyngeal cancer: Systematic review and meta-analysis.
Quan DL; Sukari A; Nagasaka M; Kim H; Cramer JD
Head Neck; 2021 Nov; 43(11):3681-3696. PubMed ID: 34323332
[TBL] [Abstract][Full Text] [Related]
17. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
[TBL] [Abstract][Full Text] [Related]
18. It is not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy.
Naik M; Ward MC; Bledsoe TJ; Kumar AM; Rybicki LA; Saxton JP; Burkey BB; Greskovich JF; Adelstein DJ; Koyfman SA
Oral Oncol; 2015 Aug; 51(8):800-4. PubMed ID: 25977228
[TBL] [Abstract][Full Text] [Related]
19. Functional outcomes and quality of life after chemoradiotherapy: baseline and 3 and 6 months post-treatment.
Lazarus CL; Husaini H; Hu K; Culliney B; Li Z; Urken M; Jacobson A; Persky M; Tran T; Concert C; Palacios D; Metcalfe-Klaw R; Kumar M; Bennett B; Harrison L
Dysphagia; 2014 Jun; 29(3):365-75. PubMed ID: 24609609
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
